Endovascular Modalites for Contralateral Common Iliac Artery in Patients With Symptomatic Unilateral Common Iliac Artery Occlusive Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Common iliac artery stenting.
- Who it may be relevant to
- Registry conditions: Iliac Artery Disease. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
To evaluate the safety, efficacy, and outcomes of endovascular strategies for protection of the contralateral CIA in patients with symptomatic unilateral CIA occlusive disease
Interventions
- Procedure Common iliac artery stenting
Stenting of common iliac artery by balloon mounted stent
Primary outcome measures
- Primary patency of both common iliac arteries [Time frame: 2 years]
Eligibility criteria
Inclusion criteria
- Symptomatic patients (Rutherford category 3- 5) due to Unilateral common iliac artery occlusive disease.
with or without combined iliac or femoropopliteal or infrapopliteal lesions.
Asymptomatic Contralateral limb.
Patent at least one run-off vessel
Exclusion criteria
- Distal aorta lesion
contralateral CIA occlusion
Previous endovascular or surgical procedures for the same lesion
Hypersensitivity to contrast material
Presence of aortic or iliac aneurysms
Patients with unsalvageable limb
Non atherosclerotic lesions
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Aboyans V, Desormais I, Lacroix P, Salazar J, Criqui MH, Laskar M. The general prognosis of patients with peripheral arterial disease differs according to the disease localization. J Am Coll Cardiol. 2010 Mar 2;55(9):898-903. doi: 10.1016/j.jacc.2009.09.055. PMID 20185041
Identifiers
NCT: NCT07012551 · Common iliac artery stenting